Viewing Study NCT07260305

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:27 AM

Ignite Modification Date: 2025-12-26 @ 2:08 AM

Study NCT ID: NCT07260305

Status: RECRUITING

Last Update Posted: 2025-12-03

First Post: 2025-11-17

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients

Sponsor: Kangabio AUSTRALIA LTD PTY

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module